Pro

GSK relocates 2,200 sales positions as part of 'growth strategy'

GSK relocates 2,200 sales positions as part of 'growth strategy'

By

GlaxoSmithKline has put a twist on pharma's strategy of slashing sales reps to improve the earnings outlook, reallocating the positions to emerging markets.

Email Newsletters

MM&M inVISION